Validation of the Japanese version of EORTC QLQ-CR38

Quality of Life Research

Volumn 17, Issue 2, 2008, Pages 317-322

  Tsunoda, A ^a   Yasuda, N ^b   Nakao, K ^c   Yokoyama, N ^a   Marumori, T ^d   Hashimoto, H ^e   Kusano, M ^a   West, K ^f  

^a SHOWA UNIVERSITY   (Japan)

^b Isezaki Municipal Hospital   (Japan)

^c Yamanashi Red Cross Hospital   (Japan)

^d Hitachi General Hospital   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f EORTC DATA CENTER   (Belgium)

Author keywords

Colorectal cancer; EORTC QLQ CR38; Japanese; Quality of life; Validation study

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; TS 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COLORECTAL CANCER; COLORECTAL CANCER SPECIFIC QUALITY OF LIFE QUESTIONNAIRE; CRONBACH ALPHA COEFFICIENT; FEMALE; FEMALE SEXUAL DYSFUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTITRAIT MULTIMETHOD; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; TEST RETEST RELIABILITY; UNSPECIFIED SIDE EFFECT; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; RADIOTHERAPY; SELF ASSESSMENT (PSYCHOLOGY);

EID: 39149093942     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-007-9298-x     Document Type: Article

References (10)

1. Aaronson, N. K., Ahmedzai, A., Berman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365-376.
2. Apoplone, G., Filiberti, A., Cifani, S., Ruggiata, R., & Mosconi, P. (1998). Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 health survey in a cohort of Italian long-survival patients. Annals of Oncology, 9, 549-557.
3. Sprangers, M. A. G., Velde, A., & Aaronson, N. K. (1999). The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Journal of Cancer, 35, 238-247.
4. Shirasaka, T., Shimamoto, Y., Ohshimo, H., Yamaguchi, M., Kato, T., Yonekura, K., & Fukushima, M. (1996). Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs, 7, 548-557.
5. Tsunoda, A., Yasuda, N., Nakao, K., Narita, K., Watanabe, M., Suzuki, N., & Kusano, M. (2007). Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer. Oncology, 72, 58-63.
6. Sprangers, M. A. G., Cull, A., Bjordal, K., Groenvold, M., & Aaronson, N. K. (1993). The European Organization for Research and Treatment of Cancer approach to quality of life assessment: Guideline for developing questionnaire modules. Quality of Life Research, 2, 287-295.
7. Kobayashi, K., Takeda, F., Teramukai, S., Gotoh, I., Sakai, H., Yoneda, S., et al. (1998). A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. European Journal of Cancer, 34, 810-815.
8. Grumann, M. M., Noack, E. M., Hoffmann, I. A., & Schlag, P. M. (2001). Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Annals of Surgery, 2, 149-156.
9. Schmidt, C. E., Bestmann, B., Kuchler, T., Longo, W. E. L., & Kremer, B. (2005). Prospective evaluation of quality of life of patients receiving either abdominoperineal resection or sphincter-preserving procedure for rectal cancer. Annals of Surgical Oncology, 12, 117-123.
10. Tsunoda, A., Shibusawa, M., Tanizaki, H., & Kusano, M. (2004). Hypogastric nerve preservation does not increase local recurrence after surgical treatment of rectal carcinoma. Hepato-Gastroenterology, 51, 1354-1357.